We Predict, Engineer, and Outcompete Pathogens

The Problem

Thanks to burgeoning anti-microbial resistance (AMR),

by 2050,

a simple sore throat could be fatal

(WHO report (2022))

Antimicrobial resistance (AMR) is one of the world's fastest-growing health threats.

By 2050, AMR is projected to reduce global GDP by 3.8%, and poised to result in 10 million direct deaths annually.

New antimicrobial technologies are urgently needed.

We are building the discovery engine for precision antimicrobials

A visualisation of a natural tailocin.

The Science

Antibiotics are chemical weapons. Pathogens evolve resistance to them.

Tailocins are nature's alternative: precision protein nanomachines that kill pathogens through a mechanical mechanism rather than chemical toxicity. This enables highly targeted antimicrobial activity while preserving beneficial bacteria.

Until now, tailocins have been difficult to engineer.

Elakistos Flame changes that.

The Solution

Our AI-driven platform,

Elakistos Flame,

reprograms tailocin nanoparticles into

precise, safe & effective antimicrobials

Our AI platform identifies the molecular signatures that determine pathogen targeting, allowing us to rapidly reprogram tailocins into development-ready antimicrobial candidates.

*We are currently raising capital to develop E-Flame into a commercially viable product.

Looking to partner with us?

Get in touch: info@elakistosbiosciences.com

Together, we can build the next generation of precision antimicrobial therapies

Awards & Recognition

We received a Fulbright grant in 2026 to accelerate the building of our AI-powered drug creation platform, E-flame. The research is conducted in collaboration with the University of Tennessee, USA.

Elakistos Biosciences was one of the few AI+Biotech start-ups selected to present a tech talk at the NEXT.BIO Conference at University of California, San Francisco in October 2025. The conference was a culmination of the 2025 Next Sequence accelerator program, that Elakistos participated in.

We were one of Bpifrance EuroQuity's top deeptech start-ups selected for their April 2025 SEADE DEEPTECH E-PITCH. Watch our 5-min pitch.

Elakistos Biosciences was awarded the best scientific research in the National Research Fund 2024 Kenya National Research Festival Poster Category.

Page updated

Report abuse